SURG vs. CRM

Last updated Jun 3, 2026

SURG (SurgePays, Inc.) and CRM (salesforce.com, inc.) are both stocks. Both operate in the Software - Application industry within the Technology sector. Over the past 5 years, SURG returned -40.95%/yr vs -4.02%/yr for CRM. At a 0.10 correlation, their price movements are largely independent.

Performance

SURG vs. CRM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in SurgePays, Inc. (SURG) and salesforce.com, inc. (CRM). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, SURG achieves a -66.67% return, which is significantly lower than CRM's -27.87% return.

SURG

• 1D: -6.58%
• 1M: -2.62%
• YTD: -66.67%
• 6M: -69.58%
• 1Y: -81.26%
• 3Y*: -58.05%
• 5Y*: -40.95%
• 10Y*: —

CRM

• 1D: -5.09%
• 1M: 2.77%
• YTD: -27.87%
• 6M: -19.82%
• 1Y: -27.39%
• 3Y*: -3.17%
• 5Y*: -4.02%
• 10Y*: 8.89%

*Multi-year figures are annualized to reflect compound growth (CAGR)

SURG vs. CRM - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018
SURG SurgePays, Inc.	-66.67%	-6.18%	-72.40%	-1.68%	224.75%	-65.62%	-60.83%	-21.05%	-69.84%
CRM salesforce.com, inc.	-27.87%	-20.25%	27.76%	98.46%	-47.83%	14.20%	36.82%	18.74%	25.79%

Correlation

The correlation between SURG and CRM is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.14
Correlation (3Y) Calculated over the trailing 3-year period	0.18
Correlation (5Y) Calculated over the trailing 5-year period	0.15
Correlation (All Time) Calculated using the full available price history since Jan 17, 2018	0.10

Fundamentals

EPS SURG : -$2.12 CRM : $8.59
PS Ratio SURG : 0.22 CRM : 4.16
Total Revenue (TTM) SURG : $50.37M CRM : $42.83B
Gross Profit (TTM) SURG : -$19.42M CRM : $33.25B
EBITDA (TTM) SURG : -$40.48M CRM : $12.32B

Return for Risk

SURG vs. CRM — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SURG

SURG Risk / Return Rank: 5
SURG Sharpe Ratio Rank: 7
SURG Sortino Ratio Rank: 5
SURG Omega Ratio Rank: 4
SURG Calmar Ratio Rank: 4
SURG Martin Ratio Rank: 5

CRM

CRM Risk / Return Rank: 12
CRM Sharpe Ratio Rank: 10
CRM Sortino Ratio Rank: 13
CRM Omega Ratio Rank: 13
CRM Calmar Ratio Rank: 15
CRM Martin Ratio Rank: 9

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SURG vs. CRM - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for SurgePays, Inc. (SURG) and salesforce.com, inc. (CRM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	SURG	CRM	Difference
Sharpe ratio Return per unit of total volatility	-0.87	-0.73	-0.14
Sortino ratio Return per unit of downside risk	-1.60	-0.89	-0.71
Omega ratio Gain probability vs. loss probability	0.77	0.89	-0.12
Calmar ratio Return relative to maximum drawdown	-0.93	-0.70	-0.24
Martin ratio Return relative to average drawdown	-1.52	-1.36	-0.16
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

SURG vs. CRM - Sharpe Ratio Comparison

The current SURG Sharpe Ratio is -0.87, which is comparable to the CRM Sharpe Ratio of -0.73. The chart below compares the historical Sharpe Ratios of SURG and CRM, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	SURG	CRM	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.87	-0.73	-0.14
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.43	-0.11	-0.32
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.25	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.40	0.46	-0.86

Drawdowns

SURG vs. CRM - Drawdown Comparison

The maximum SURG drawdown since its inception was -99.21%, which is greater than CRM's maximum drawdown of -70.50%. Use the drawdown chart below to compare losses from any high point for SURG and CRM.

Drawdown Indicators

	SURG	CRM	Difference
Max Drawdown Largest peak-to-trough decline	-99.21%	-70.50%	-28.71%
Max Drawdown (1Y) Largest decline over 1 year	-85.42%	-39.46%	-45.96%
Max Drawdown (3Y) Largest decline over 3 years	-94.42%	-54.70%	-39.72%
Max Drawdown (5Y) Largest decline over 5 years	-94.42%	-58.62%	-35.80%
Max Drawdown (10Y) Largest decline over 10 years	—	-58.62%	—
Current Drawdown Current decline from peak	-99.12%	-47.66%	-51.46%
Average Drawdown Average peak-to-trough decline	-85.38%	-16.10%	-69.28%
Ulcer Index Depth and duration of drawdowns from previous peaks	52.53%	20.18%	+32.35%

Volatility

SURG vs. CRM - Volatility Comparison

SurgePays, Inc. (SURG) has a higher volatility of 19.68% compared to salesforce.com, inc. (CRM) at 17.31%. This indicates that SURG's price experiences larger fluctuations and is considered to be riskier than CRM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	SURG	CRM	Difference
Volatility (1M) Calculated over the trailing 1-month period	19.68%	17.31%	+2.37%
Volatility (6M) Calculated over the trailing 6-month period	86.47%	31.96%	+54.51%
Volatility (1Y) Calculated over the trailing 1-year period	94.29%	37.89%	+56.40%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	95.81%	37.02%	+58.79%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	107.68%	35.34%	+72.34%

Dividends

SURG vs. CRM - Dividend Comparison

SURG has not paid dividends to shareholders, while CRM's dividend yield for the trailing twelve months is around 0.89%.

Position	TTM	2025	2024
CRM salesforce.com, inc.	0.89%	0.63%	0.48%
SURG SurgePays, Inc.	0.00%	0.00%	0.00%

Financials

Frequently Asked Questions

Can I hold both SURG and CRM in my portfolio?

SURG and CRM have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, SURG or CRM?

SURG has higher volatility (19.68%) compared to CRM (17.31%). In terms of maximum drawdown, SURG dropped -99.21% vs CRM's -70.50%.

Which has better risk-adjusted returns?

CRM currently has the higher Sharpe Ratio (-0.73 vs -0.87), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.